Full text is available at the source.
Abstract
Ketamine may initiate neuroplastic changes within hours to days, leading to rapid antidepressant effects.
- Ketamine primarily acts by blocking the NMDA receptor, which triggers a series of signaling events in the brain.
- These events promote synaptic plasticity and neurogenesis, contributing to quick relief from depressive symptoms.
- Preclinical evidence shows that ketamine influences BDNF signaling, activates the mTOR pathway, and modulates AMPA receptors.
- Clinical studies indicate that the timing of ketamine's antidepressant effects correlates with these biological changes.
- The review highlights the need for further research to bridge gaps between preclinical findings and clinical outcomes.
Simplified